Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-097458
Filing Date
2024-09-05
Accepted
2024-09-05 18:42:08
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423290-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2423290-1_3seq1.xml 3 8983
  Complete submission text file 0001104659-24-097458.txt   11681
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 30 GREYLOCK ROAD WELLESLEY MA 02481
Business Address
Ciongoli Gregory Austin (Reporting) CIK: 0002023732 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 241282541

Mailing Address 30 GREYLOCK ROAD WELLESLEY MA 02481
Business Address 30 GREYLOCK ROAD WELLESLEY MA 02481 781-235-7974
Adiumentum Capital Fund I LP (Reporting) CIK: 0002023734 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 241282543

Mailing Address 30 GREYLOCK ROAD WELLESLEY MA 02481
Business Address 30 GREYLOCK ROAD WELLESLEY MA 02481 781-235-7974
Adiumentum Capital Fund I GP LLC (Reporting) CIK: 0002023736 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 241282542